This inventor holds 1 USPTO granted patent. Top assignee: Iowa State University Research Foundation Inc.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Sergey Artiushin: Innovator in PCR-Based Assays
Introduction
Sergey Artiushin is a notable inventor based in Ames, Iowa. He has made significant contributions to the field of molecular diagnostics, particularly through his work on PCR-based assays. His innovative approach has the potential to enhance the detection of specific pathogens, thereby improving diagnostic accuracy.
Latest Patents
Sergey Artiushin holds a patent for a PCR-based assay for Mycoplasma hyopneumoniae. This patent includes a species-specific primer pair designed for use in the assay, along with a related diagnostic kit. The primer pair consists of two oligonucleotides with the following nucleotide sequences: 5'-AAGTTCATTCGCGCTAGCCC-3' and 5'-GCTCCTACTCCATATTGCCC-3'. Additionally, the kit is designed to contain an oligonucleotide probe with the sequence 5'-GGTAGCCCTTCCTTTGAGGT-3'. This innovation represents a significant advancement in the field of veterinary diagnostics.
Career Highlights
Sergey Artiushin is affiliated with the Iowa State University Research Foundation Inc., where he continues to contribute to research and development in molecular biology. His work has been instrumental in advancing diagnostic techniques that are crucial for animal health.
Collaborations
Throughout his career, Sergey has collaborated with esteemed colleagues, including Laszlo Stipkovits and F Chris Minion. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
In summary, Sergey Artiushin is a dedicated inventor whose work in PCR-based assays has the potential to significantly impact the field of diagnostics. His contributions, particularly in the detection of Mycoplasma hyopneumoniae, highlight the importance of innovation in improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile